Single and Multiple Ascending Doses of AZD1981 in Japan
NCT00698282 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47
Last updated 2010-12-01
Summary
The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects
Conditions
- Healthy
Interventions
- DRUG
-
AZD1981
Oral tablet, 250 mg single dose
- DRUG
-
AZD1981
Suspension, 15, 75, 1000 and 2000 mg
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Elizabeth Hancox · Europe Chiltern International Ltd, Berkshire, UK
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2008-10-31
- Completion
- 2008-10-31
Countries
- United Kingdom
More Related Trials
-
AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00912353 ·Status: COMPLETED ·Phase: PHASE1
-
To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects
NCT00738322 ·Status: COMPLETED ·Phase: PHASE1
-
AZD2624 Multiple Ascending Dose Study in Japan
NCT00696865 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
NCT00687232 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00886756 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
NCT07222254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
NCT06995820 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject
NCT01021189 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers
NCT01116011 ·Status: COMPLETED ·Phase: PHASE1
-
AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects
NCT01114152 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects
NCT00766012 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.
NCT06519968 ·Status: COMPLETED ·Phase: PHASE1
-
AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects
NCT00935025 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers
NCT06951880 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
AZD Single Ascending Dose Study In Healthy Japanese Subjects
NCT01028040 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers
NCT01392820 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
NCT07290283 ·Status: RECRUITING ·Phase: PHASE1
-
AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects
NCT00769899 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses
NCT01199315 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers
NCT00741689 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00767052 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers
NCT04994106 ·Status: COMPLETED ·Phase: PHASE1
-
Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069
NCT01100047 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers
NCT01233830 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
NCT06502379 ·Status: COMPLETED ·Phase: PHASE1